Opinion: Making naloxone available over the counter won’t solve the overdose crisis — but it will help
The Food and Drug Administration aims to conduct priority reviews of at least two product…
Author: STAT
STAT+: The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals
WASHINGTON — Congress just boosted the FDA’s authority over the post-market clinical trials that are…
The drug was meant to save children’s lives. Instead, they’re dying
Emily was combing her baby daughter’s hair when she first felt the lumps. It was…
STAT+: New results show Cassava’s Alzheimer’s drug has placebo-like efficacy
Cassava Sciences had long claimed that its experimental treatment for Alzheimer’s disease was capable of…
STAT+: Doctors’ group complains that 60 Minutes segment on Wegovy was really just an ad
A physicians’ group has filed a complaint with the U.S. Food and Drug Administration alleging…
Amazon Prime for your prescriptions, virtual care during pregnancy, & AI for mental health
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
.jpg)
Study of pancreatitis surgery patients finds steady decline in survival and need for better addiction support
For some people with chronic pancreatitis, surgery is the only hope. The condition can cause…
STAT+: Health systems have much higher prices, only marginally better quality, new study finds
The claims have become almost ubiquitous. Hospital CEO after hospital CEO stands at a podium…
Promising gene therapy delivers treatment directly to brain
When Rylae-Ann Poulin was a year old, she didn’t crawl or babble like other kids…
STAT+: Pharmalittle: Amazon adds $5 monthly generic drug subscription; PhRMA ends lobbying contract with brother of White House official
Rise and shine, everyone, another busy day is on the way. We can tell thanks…
STAT+: Amazon Pharmacy expands with new $5 monthly prescription service
Amazon is launching a new prescription service that lets patients on Amazon Prime get eligible…
STAT+: Many pediatric drug study results were never posted to a U.S. government database
Amid ongoing controversy over clinical trial transparency, a new analysis found that results of 43…
Opinion: It’s time to retire ‘poor historian’ from clinicians’ vocabularies
Should we pity the “poor historian” — the individual or family member who can’t give…
Predictive biomarkers could ease the exhaustive trial-and-error of antidepressants
When a patient is suffering from depression and considering medication, practically all physicians have the…
Technology could improve pregnancy care for low-income patients — if health systems can pay for it
For low-income patients, the challenges of pregnancy are only compounded by the challenges of prenatal…
STAT+: ‘I’m just disgusted’: How alleged sexual misconduct stole one student’s passion for academic science
It was the summer of 2020, and she couldn’t have scripted a better start as…
.jpg)
STAT+: Calico looking for new chief scientist after celebrated biologist David Botstein quietly retires
Are you a promising middle or late-career scientist with a desire to extend human lifespan,…
STAT+: Liquid-biopsy firm Grail is spending more than ever lobbying Congress
Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the…
STAT+: Health groups like AHA, PhRMA channeled millions into end-of-year legislative debates
WASHINGTON — Health care groups and their lobbyists spent big in the last few months…
STAT+: PhRMA terminates lobbying contract with White House official’s brother
WASHINGTON — The pharmaceutical industry lobbying group PhRMA has severed its contract with a lobbyist who…
Chatbots are creating thorny ethical questions about transparency in mental health care
The mental health field is increasingly looking to chatbots to relieve escalating pressure on a…
STAT+: Despite court ruling, FDA will continue with its approach to approving orphan drug exclusivity
In an unexpected move, the U.S. Food and Drug Administration will continue to apply exclusive…
FDA scientists propose an annual Covid shot matched to current strains
Scientists at the Food and Drug Administration propose making Covid vaccination a regular, once-a-year shot…
STAT+: Pharmalittle: Obesity guidelines cause backlash; Bayer is pushed to spin off its consumer health business
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pliant claims early success in hard-to-treat progressive lung disease
Pliant Therapeutics said Sunday that an experimental pill significantly improved lung function in patients with…
Opinion: DEI policies won’t stop discrimination in hiring. That requires fighting unconscious bias
At least on paper, businesses and institutions have achieved equality through thoughtful diversity, equity, and…
STAT+: As more never-smokers develop lung cancer, researchers test an AI model to predict patient risk
Massachusetts General Hospital is launching a prospective trial of an artificial intelligence tool designed to…
STAT+: A different kind of ‘RAC’ subsidized hospitals’ labor during the pandemic
Hospitals have bemoaned rising employee expenses throughout the pandemic, as they’ve paid workers more to…
STAT+: How one private biotech seized on JPM to emerge from stealth and tell its story
SAN FRANCISCO — The team behind Rezo Therapeutics, a new biotech co-founded by a group…
Make 2023 the year of prioritizing women’s health
Thirty years ago this week, the bill that became the National Institutes of Health Revitalization…
STAT+: ‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year
It’s hard to overstate the Boston biotechnology industry’s astronomical growth, which has overflowed from its…
Prosecutors: Convicted CEO Elizabeth Holmes is a flight risk
SAN JOSE, Calif. (AP) — Elizabeth Holmes is a flight risk and shouldn’t be allowed…
STAT+: FTC wants ‘pharma bro’ Martin Shkreli held in contempt for violating lifelong ban on working in pharma
The U.S. Federal Trade Commission asked a federal judge to hold “pharma bro” Martin Shkreli…
Buprenorphine deaths did not increase despite wider access during pandemic, study shows
The onset of the Covid-19 pandemic led to a sea change in addiction medicine —…
STAT+: Pharmalittle: FDA rejects Lilly application for Alzheimer’s drug; Sanofi offers a warranty for a medicine
And so, another working week will soon draw to a close. Not a moment too…
Opinion: The WHO’s new pandemic treaty is good for the world — and the U.S.
In December, delegates from more than 180 countries met in Switzerland to discuss the International…
Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is
On Target is a recurring feature from STAT that dives deep into the most promising…
Opinion: Even with lawsuits and copay caps, will insulin ever be affordable?
In an attempt to tackle the root causes of the inflated cost of insulin, the…
STAT+: FDA rejects Lilly’s bid for accelerated approval for its Alzheimer’s drug
Eli Lilly said Thursday that U.S. regulators had rejected its application seeking accelerated approval for…
STAT+: ‘A cascade of failures’: FDA cites Indian drugmaker for numerous quality control problems
In a stunning rebuke, the U.S. Food and Drug Administration accused a drugmaker of a…
STAT+: Pallone pushes NIH and FDA to disclose steps being taken to ensure clinical trial results are reported
A Democratic lawmaker is demanding to know what steps the U.S. Food and Drug Administration…
STAT+: For only the second time, a big drugmaker offers a warranty on a medicine
In a bid to blunt competition and address rising drug costs, Sanofi is offering a…
Listen: How blockbusters get made, new vaccines for RSV, and mRNA’s Q score
Where do new drugs come from? Does science need billionaires? And do normal people care…
STAT+: Will the European Union give vouchers to pharma to develop badly needed antibiotics?
Amid rising concern over antibiotic resistance, a battle is brewing in Europe over a proposal…
STAT+: Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
With Gates Foundation backing, a health tech company aims to speed diagnosis of some neglected tropical diseases
As it looks to curb the spread of infectious diseases, the Gates Foundation is lending…
Opinion: Upcoding: one reason Medicare Advantage companies pay clinicians to make home health checkups
At the start of 2023, an estimated 2.5 million Americans age 65 and older began…
A new study links social media use to changes in teen brains. Is that a bad thing?
Today’s teens and tweens have never known a world without social media. There are still…
Opinion: Medical school rankings need a new metric: economic mobility index
What are the attributes of a great medical school? U.S. News & World Report’s ranking…
In a post-Dobbs world, pathologists who study pregnancy loss walk a thin line between medicine and the law
When Mana Parast examines a placenta, she knows she may never find the answers she…